Ovoca Bio (DUB:OVXA) YoY EBITDA Growth : 59.70% (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Ovoca Bio YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ovoca Bio's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 59.70%.

Ovoca Bio's EBITDA per Share for the six months ended in Jun. 2023 was €-0.03.

Ovoca Bio YoY EBITDA Growth Historical Data

The historical data trend for Ovoca Bio's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio YoY EBITDA Growth Chart

Ovoca Bio Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

-1,100.00

8.33

-22.73

-133.33

1.59

Ovoca Bio Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EBITDA Growth	Get a 7-Day Free Trial															-48.00	-766.67	-81.08	119.23	59.70

Ovoca Bio YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ovoca Bio's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-0.062	-	-0.063)	/	\| -0.063 \|
=	1.59 %

Ovoca Bio's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2023 )
=	(EBITDA per Share (Q: Jun. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(-0.027	-	-0.067)	/	\| -0.067 \|
=	59.70 %

Ovoca Bio YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ovoca Bio's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovoca Bio (DUB:OVXA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (DUB:OVXA) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

OVB.GB:UK OVB:UK OVXA:Germany

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio (DUB:OVXA) Headlines

No Headlines